Next Day Disclosure Returns - [Share Buyback]

Jacobio Pharmaceuticals Co. Ltd. operates as a biotech company. The Company develops and sells cancer innovative drugs, autoimmune drugs, infectious diseases drugs, and other products. Jacobio Pharmaceuticals markets its products throughout China.

Next Day Disclosure Return

Announcements and Notices - [Other - Miscellaneous]

Voluntary Announcement
Intention To Conduct On-Market Share Repurchase

Announcements and Notices - [Other - Business Update]

Voluntary Announcement
Jacobio Completed The First Patient Dosage In The Phase I/Iia
Clinical Trial Of Pan-Kras Inhibitor Jab-23e73 In U.S.

Seventh Amended And Restated Memorandum And Articles Of Association

Announcements and Notices - [Results of AGM / Amendment of Constitutional Documents]

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Jacobio Pharmaceuticals (1167 HK)

Next Day Disclosure Return

Voluntary Announcement Intention To Conduct On-Market Share Repurchase

Voluntary Announcement Jacobio Completed The First Patient Dosage In The Phase I/Iia Clinical Trial Of Pan-Kras Inhibitor Jab-23e73 In U.S.

Seventh Amended And Restated Memorandum And Articles Of Association

Poll Results Of The Annual General Meeting Held On June 10, 2025

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)